Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bertagna

Showing results (151-160 of 265) with videos related to

Pageof 27
Sort By:
Nuclear Medicine Communications|February 13, 2020
Three years' clinical practice of Radium-223 therapy in patients with symptomatic bone metastases from metastatic castrate-resistant prostate cancer: a single-centre experienceMaria Gazzilli, Rexhep Durmo, Erika Cossalter, et al.
Respiratory Medicine Case Reports|August 22, 2018
Pulmonary hamartoma mimicking a mediastinal cyst-like lesion in a heavy smokerAndrea Borghesi, Andrea Tironi, Mauro Roberto Benvenuti, et al.
Annals of Surgical Oncology|July 4, 2012
Searching for indicators of malignancy in pancreatic intraductal papillary mucinous neoplasms: the value of 18FDG-PET confirmedGian Luca Baiocchi, Francesco Bertagna, Federico Gheza, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2004
Value of gated SPECT in the analysis of regional wall motion of the interventricular septum after coronary artery bypass graftingRaffaele Giubbini, Pierluigi Rossini, Francesco Bertagna, et al.
Cancers|February 25, 2023
Temporal Evolution and Prognostic Role of Indeterminate Response Sub-Groups in Patients with Differentiated Thyroid Cancer after Initial Therapy with RadioiodineDomenico Albano, Pietro Bellini, Francesco Dondi, et al.
Japanese Journal of Radiology|July 17, 2021
Clinical and prognostic <sup>18</sup>F-FDG PET/CT role in recurrent vulvar cancer: a multicentric experienceDomenico Albano, Mattia Bonacina, Giordano Savelli, et al.
Nuclear Medicine Communications|January 2, 2013
Production and quality control of [(90)Y]DOTATOC for treatment of metastatic neuroendocrine tumors: results of 85 synthesesGiorgio Biasiotto, Francesco Bertagna, Isabella Zanella, et al.
Pharmaceuticals (Basel, Switzerland)|November 13, 2020
Role of 2-[<sup>18</sup>F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic ReviewSalvatore Annunziata, Roberto C Delgado Bolton, Christel-Hermann Kamani, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 25, 2022
The role of [18F]FDG PET/CT in paraneoplastic autoimmune disorders: an umbrella reviewBarbara Muoio, Domenico Albano, Francesco Dondi, et al.
Diagnostics (Basel, Switzerland)|July 27, 2024
The Potential Role of PSMA-Targeted PET in Salivary Gland Malignancies: An Updated Systematic ReviewAlessio Rizzo, Domenico Albano, Federica Elisei, et al.
Pageof 27

Showing results (151-160 of 265) with videos related to

Sort By:
Pageof 27
Nuclear Medicine Communications|February 13, 2020
Three years' clinical practice of Radium-223 therapy in patients with symptomatic bone metastases from metastatic castrate-resistant prostate cancer: a single-centre experienceMaria Gazzilli, Rexhep Durmo, Erika Cossalter, et al.
Respiratory Medicine Case Reports|August 22, 2018
Pulmonary hamartoma mimicking a mediastinal cyst-like lesion in a heavy smokerAndrea Borghesi, Andrea Tironi, Mauro Roberto Benvenuti, et al.
Annals of Surgical Oncology|July 4, 2012
Searching for indicators of malignancy in pancreatic intraductal papillary mucinous neoplasms: the value of 18FDG-PET confirmedGian Luca Baiocchi, Francesco Bertagna, Federico Gheza, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2004
Value of gated SPECT in the analysis of regional wall motion of the interventricular septum after coronary artery bypass graftingRaffaele Giubbini, Pierluigi Rossini, Francesco Bertagna, et al.
Cancers|February 25, 2023
Temporal Evolution and Prognostic Role of Indeterminate Response Sub-Groups in Patients with Differentiated Thyroid Cancer after Initial Therapy with RadioiodineDomenico Albano, Pietro Bellini, Francesco Dondi, et al.
Japanese Journal of Radiology|July 17, 2021
Clinical and prognostic <sup>18</sup>F-FDG PET/CT role in recurrent vulvar cancer: a multicentric experienceDomenico Albano, Mattia Bonacina, Giordano Savelli, et al.
Nuclear Medicine Communications|January 2, 2013
Production and quality control of [(90)Y]DOTATOC for treatment of metastatic neuroendocrine tumors: results of 85 synthesesGiorgio Biasiotto, Francesco Bertagna, Isabella Zanella, et al.
Pharmaceuticals (Basel, Switzerland)|November 13, 2020
Role of 2-[<sup>18</sup>F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic ReviewSalvatore Annunziata, Roberto C Delgado Bolton, Christel-Hermann Kamani, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 25, 2022
The role of [18F]FDG PET/CT in paraneoplastic autoimmune disorders: an umbrella reviewBarbara Muoio, Domenico Albano, Francesco Dondi, et al.
Diagnostics (Basel, Switzerland)|July 27, 2024
The Potential Role of PSMA-Targeted PET in Salivary Gland Malignancies: An Updated Systematic ReviewAlessio Rizzo, Domenico Albano, Federica Elisei, et al.
Pageof 27